Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Authors › Posts by Kyle Diamantas

Kyle Diamantas

Read the latest stories and analysis from Kyle Diamantas.

The White House lit up in pink for breast cancer awareness. Op-Eds

Pink ribbons to precision medicine: How Trump’s FDA is stepping up against breast cancer

Kyle Diamantas · October 18, 2026 5:00 am
Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee recently voted against recommending the approval of MDMA-assisted therapy for the treatment of PTSD. Op-Eds

Stop forcing vets abroad: Trump’s FDA is bringing a game-changing PTSD treatment home

Kyle Diamantas, Mike Davis · October 6, 2026 5:00 am
President Donald Trump speaks during an event to promote investment in rural health care in the East Room of the White House, Friday, Jan. 16, 2026, in Washington, with Secretary of Health and Human Services, Robert F. Kennedy, Jr., and Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services. Op-Eds

Pancreatic cancer had a 13% survival rate. Trump’s FDA just changed everything

Kyle Diamantas · September 19, 2026 7:00 am
Advertisement
  • 1
Page 1 of 1
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement